Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,470,595
-$93,650 QoQ
Shares Held
134,917
+11.5% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $59,438,019 across 6 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
148,816 | $22,657,236 | |
| 2 | BBNX |
Beta Bionics, Inc.
|
1,249,441 | $19,578,740 | |
| 3 | BRKR |
Bruker Corp
|
182,894 | $11,006,560 | |
| 4 | GKOS |
GLAUKOS Corp
|
29,343 | $4,100,977 | |
| 5 | AVR |
Anteris Technologies Global Corp.
|
166,229 | $1,637,355 | |
| 6 | SSII |
SS Innovations International, Inc.
|
110,157 | $457,151 |
All Filings in NVCR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,470,595 | 134,917 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,564,245 | 120,978 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||